Inmunotek
Xavier Calvo Briante is a CQV Expert at PQE Group since October 2022, specializing in the management of qualification and test plans, as well as drafting and executing qualification protocols. Prior experience includes serving as a Validation Technician at Dara Pharmaceutical Equipment from July 2020 to October 2022, where responsibilities encompassed writing qualification documentation and executing protocols. Xavier also worked as a Validation Consultant at PQE Group from October 2018 to July 2020, focusing on client collaborations and validation processes. Earlier in 2018, Xavier was a Research Assistant at the Institut de Biomedicina de la Universitat de Barcelona, contributing to research on nuclear receptors. Xavier holds a Postgraduate degree in Quality Systems for the Pharmaceutical Industry and Pharmaceutical Research from Universitat de Barcelona.
This person is not in any teams
This person is not in any offices
Inmunotek
INMUNOTEK is a pharma company which researches, develops, manufactures and distributes therapeutic vaccines in the fields of allergy, infectious diseases and cancer. In addition, the company develops, manufactures and sells medical devices. INMUNOTEK was founded in 1992 with the mission of improving the quality of life of patients and providing value to healthcare professionals, by creating innovative, safe and effective products. INMUNOTEK's products are sold in both Spain and in more than 50 other countries around the world through our subsidiaries, sales offices and exclusive distributors. Our two production centres are based in the towns of San Sebastián de los Reyes and Alcalá de Henares (Madrid, Spain).